While neutralization of IL-17 in a CF mouse model demonstrated protection against lung inflammation from PA (Hsu et al., 2016), other investigators found that Il-17ra-deficient mice exhibited higher mortality post-infection (Bayes et al., 2016). This evidence concerns the gene IL17A and cystic fibrosis.